Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
2013 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
1999 Standout
Reproductive life disorders in Italian celiac women. A case-control study
2010
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Predictors of Long-term Progression in the Early Manifest Glaucoma Trial
2007 Standout
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
A challenge for regenerative medicine: Proper genetic programming, not cellular mimicry
2007
Infections and cancer: Established associations and new hypotheses
2008
Hepatocellular carcinoma
2016 Standout
Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
2013
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Pancreatic cancer
2020 Standout
A New Modified Concomitant Therapy for Helicobacter pylori Eradication in Turkey
2011
Importance of antimicrobial susceptibility testing for the management of eradication inHelicobacter pyloriinfection
2017
Inflammation, But Not Telomere Length, Predicts Successful Ageing at Extreme Old Age: A Longitudinal Study of Semi-supercentenarians
2015
Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy for the prevention of recurrent bleeding from peptic ulcer
2004
Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma
2003
Is PCOS an inflammatory process?
2011
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2007
Epidemiological study of gastro‐oesophageal reflux disease: reflux in spouse as a risk factor
2008
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Antibody-Based Detection Tests for the Diagnosis of Helicobacter pylori Infection in Children: A Meta-Analysis
2008
Crohn's disease
2012 Standout
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
2005
The Oslo definitions for coeliac disease and related terms
2012 Standout
Pancreatic cancer
2016 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis
2009
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
2011
Helicobacter pylori and Extragastric Diseases – Other Helicobacters
2004
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2015
Outcome of EMR as an alternative to surgery in patients with complex colon polyps
2016
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Irritable bowel syndrome
2016 Standout
Endoscopic resection is cost-effective compared with laparoscopic resection in the management of complex colon polyps: an economic analysis
2015
HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1
2003
Colorectal cancer
2019 Standout
Non-alcoholic fatty liver disease
2021 Standout
Colectomy with ileostomy for severe ulcerative colitis-postoperative complications and risk factors
2019
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Clinical effects of Helicobacter pylori outside the stomach
2013
Complications of gastro-oesophageal reflux disease
2013
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
2003
Immunity, Inflammation, and Cancer
2010 Standout
Accuracy of GastroPanel for the diagnosis of atrophic gastritis
2014
Helicobacter pylori and Extragastric Diseases – Other Helicobacters
2005
The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study
2022
The 5‐HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment
2010
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
CagA antigen of helicobacter pylori and coronary instability: Insight from a clinico-pathological study and a meta-analysis of 4241 cases
2008
Global burden of liver disease: 2023 update
2023 Standout
Ulcerative colitis
2016 Standout
Chronic ulcerative colitis and colorectal cancer
2013
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
2009
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Ulcerative colitis
2020 Standout
Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy
2011
Comparison of three different second‐line quadruple therapies including bismuth subcitrate in Turkish patients with non‐ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14‐day standard first‐line therapy
2007
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Systematic review: the evidence base for long‐term management of coeliac disease
2008
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Non–Gastrointestinal Tract Associations of Helicobacter pylori Infection
1999
Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study
2020
Inflammation in obesity, diabetes, and related disorders
2022 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Association betweenHelicobacterspp. infections and hepatobiliary malignancies: A review
2015
A Sick Eye in a Sick Body? Systemic Findings in Patients with Primary Open-angle Glaucoma
2006
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Helicobacter hepaticus Hydrogenase Mutants Are Deficient in Hydrogen-Supported Amino Acid Uptake and in Causing Liver Lesions in A/J Mice
2005
Fecal biomarkers in inflammatory bowel disease: how, when and why?
2017
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
2021
Psoriasis Pathogenesis and Treatment
2019 Standout
Cloning, Expression, and Catalytic Activity of Helicobacter hepaticus Urease
2001
Chronic hepatitisC virus infection and lymphoproliferative disorders: Mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, andB ‐cell non‐H odgkin lymphoma
2014
Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
2004
‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
2014
Helicobacter species infection may be associated with cholangiocarcinoma: a meta-analysis
2013
Occurrence, Classification, and Biological Function of Hydrogenases: An Overview
2007 Standout
Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori Eradication
2007
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Combination therapy in combating cancer
2017 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Helicobacter pylori Infection as a Risk Factor for Hepatocellular Carcinoma: A Case-Control Study in Ethiopia
2018
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Iron-Deficiency Anemia
2015 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
2015
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
The impact of hepatitis C burden: an evidence‐based approach
2014
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Helicobacter pylori and Extragastric Diseases
2014
Works of Rinaldo Pellicano being referenced
The Effect of the Eradication of Helicobacter pylori Infection on Hemorrhage Because of Duodenal Ulcer
2001
Helicobacterspecies sequences in liver samples from patients with and without hepatocellular carcinoma
2004
Infections with Helicobacter pylori and challenges encountered in Africa
2019
Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?
2000
Elevated serum chromogranin A in patients with hepatocellular carcinoma.
2002
Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis
2000
Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders
2014
Azathioprine, Mucosal Healing in Ulcerative Colitis, and the Chemoprevention of Colitic Cancer: A Clinical-Practice-Based Forecast
2010
Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease
2008
Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study
2019
Liver fibrosis: the 2017 state of art
2017
Is there an association between Helicobacter pylori infection and coronary heart disease?
1999
Incidence of Type 2 Diabetes Mellitus and Glucose Abnormalities in Patients With Chronic Hepatitis C Infection by Response to Treatment: Results of a Cohort Study
2008
Insulated-Tip Knife Endoscopic Mucosal Resection of Large Colorectal Polyps Unsuitable for Standard Polypectomy
2007
Helicobacter species and liver diseases: association or causation?
2008
Helicobacters and Extragastric Diseases
2009
Helicobacter pylori Seroprevalence in Patients with Autoimmune Hepatitis
2002
Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures
2004
Helicobacter pylori infection in patients with Hepatitis C Virus positive chronic liver diseases.
2003
Helicobacter pylori seropositivity in patients with unstable angina.
2003
Women and celiac disease: association with unexplained infertility.
2007
Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study.
2001
GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
2014
A 2016 panorama of Helicobacter pylori infection: key messages for clinicians.
2016
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE data.
2009
Helicobacter pyloriiseroprevalence in hepatitis C virus positive patients with cirrhosis
2000
Gastrointestinal damage by non-steroidal anti-inflammatory drugs: updated clinical considerations.
2014
Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study.
2002
How accurate is the culture of Helicobacter pylori in a clinical setting? An appraisal.
2005
Helicobacter pylori infection in patients with arterial obstruction
1998
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease.
2014
Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference?
2002
Helicobacter pylori infection and acute myocardial infarction in Northern Italy
1998
Endoscopic ultrasonography for pancreatic cancer: current and future perspectives.
2013
Helicobacter pylori infection and diabetes mellitus: the 2013 state of art.
2013
Noninvasive assessment of liver fibrosis: key messages for clinicians
2014
The epidemiology of gastro-oesophageal reflux disease. A brief review.
2003
Association of Helicobacter pylori infection with ischemic stroke of non-cardiac origin: the BAT.MA.N. project study.
2002
Pancreatic cancer imaging: the new role of endoscopic ultrasound.
2007
Anal transitional zone adenocarcinoma following restorative proctocolectomy for ulcerative colitis: case report and review of literature.
2010
Stem cells and Helicobacter-induced gastric cancer: where do we stand at the end of 2006.
2006